Neuroectodermal Tumour Treatment in India

Neuroectodermal tumour treatment is not specified by a single method. There are various causes and different treatment options for these tumours. Neuroectodermal tumours (NETs) are rare, aggressive cancers that arise from neuroectodermal cells—primitive cells of the nervous system. These tumours can occur in the central nervous system, peripheral nerves, or soft tissues. Common examples include medulloblastomas, primitive neuroectodermal tumours (PNETs), and Ewing’s sarcoma. Effective treatment requires a multidisciplinary approach that considers tumour location, stage, age of the patient, and overall health.

What Are Neuroectodermal Tumours?

Neuroectodermal tumours (NETs) are a group of rare, aggressive cancers that originate from neuroectodermal cells, early cells in the developing nervous system. These tumours can occur in the brain, spinal cord, peripheral nerves, or soft tissues. They are most common in children and young adults and include types such as medulloblastomas, primitive neuroectodermal tumours (PNETs), and Ewing’s sarcoma. Because they can grow quickly and spread, timely diagnosis and a multidisciplinary treatment approach are essential for improving outcomes.

Book Appointment

Get a free quote

Neuroectodermal Tumours Examples

Neuroectodermal tumours are a diverse group with varying clinical behaviours, locations, and histology. They may occur at any age, but infants are more prone to these conditions. Here are the specific conditions that show Neuroectodermal Tumours.

Medulloblastoma

One of the most recognised examples is Medulloblastoma, a malignant brain tumour most commonly found in children. It typically arises in the cerebellum and presents with symptoms like headaches, balance issues, and vomiting. Another significant type is Ewing's Sarcoma, which often originates in bones or soft tissue and affects adolescents and young adults. It’s categorised under peripheral primitive neuroectodermal tumours (pPNETs).

Central Primitive Neuroectodermal Tumours (cPNETs)

Primitive Central Neuroectodermal Tumours (cPNETs) are aggressive tumours in the brain and spinal cord, requiring intensive multimodal treatment. Neuroblastoma is another neuroectodermal tumour seen predominantly in infants and young children. It arises in adrenal glands or nerve tissue and can spread rapidly.

Esthesioneuroblastoma

Other rarer forms include Esthesioneuroblastoma (in the nasal cavity) and Pineoblastoma (arising from the pineal gland). These tumours can present with varied symptoms depending on their location, including vision problems, seizures, or hormonal disturbances.

Each of these tumours demands a specific treatment approach, often combining surgery, chemotherapy, and radiation. Early diagnosis and tailored therapy have a significant impact on survival outcomes. These examples illustrate the complexity and urgency of managing neuroectodermal tumours in both children and adults.

Who is Prone to Neuroectodermal Cancers?

Neuroectodermal tumours primarily affect children, adolescents, and young adults, though they can occur at any age. The risk is higher in individuals with certain genetic syndromes, such as Li-Fraumeni syndrome or neurofibromatosis. Children under the age of 10 are particularly vulnerable to central nervous system tumours like medulloblastoma. Ewing’s sarcoma, a peripheral neuroectodermal tumour, often affects teenagers and young adults, with a slightly higher occurrence in males. Although the exact cause remains unclear, environmental exposures and genetic predisposition may contribute to risk.

Children and Adolescents: Most commonly affected, especially under 10 years of age
Young Adults: Especially those with peripheral PNETs like Ewing's sarcoma
Genetic Syndromes: Conditions like Li-Fraumeni syndrome and neurofibromatosis increase risk
Gender** Factor:** Slightly higher occurrence in males
Environmental Exposure: Though not clearly defined, some chemicals and radiation may play a role.

Book Appointment

Get a free quote

Different Treatment For Neuroectodermal Tumours- What is the treatment for PNET?

Like other diseases, there are different treatments, such as surgery, chemotherapy, and stem cell implantation. Treatment is often multimodal, combining surgery, chemo, and radiation for the best results. Early diagnosis and personalised treatment plans improve outcomes.

Neuroectodermal Tumours Treatment is combined with several clinical trials and palliative care. Clinical trials are research studies that test new treatments or drug combinations. Here are the different treatment options for Neuroectodermal Tumours (NETs), depending on the type, location, and stage of the tumour:

Different Treatment For Neuroectodermal Tumor

Surgery

Surgery is often the first line of treatment for neuroectodermal tumours when the tumour is localized and operable. The main goal is to remove the entire tumour with clear margins to prevent it from coming back. This approach is particularly useful for peripheral tumours or those in parts of the body where surgical access is relatively safe. In some cases, surgery may be followed by other treatments like chemotherapy or radiation to kill any remaining cancer cells. Surgical removal can also relieve symptoms caused by pressure on nearby organs or tissues.

Radiation Therapy

Radiation therapy uses high-energy beams to target and kill cancer cells. It is often used when surgery cannot completely remove the tumour or when the tumour is in a location that makes surgery difficult. This treatment helps to control the local growth of the tumour and can also be used to relieve pain or other symptoms. External beam radiation therapy (EBRT) is the most common method used. Radiation is frequently combined with chemotherapy for a more effective response, especially in central nervous system tumours.

Targeted Therapy

Targeted therapy focuses on specific molecules or genetic mutations that help cancer cells grow. Unlike chemotherapy, which affects all rapidly dividing cells, targeted therapy is designed to interfere with cancer cell growth pathways. Some neuroectodermal tumours may express genetic markers that can be blocked by targeted drugs, such as imatinib. These therapies are still being studied and are not yet standard for all types of NETs, but they offer a promising future for personalised treatment with fewer side effects.

Chemotherapy

Chemotherapy is commonly used for treating aggressive neuroectodermal tumours, especially in cases like primitive neuroectodermal tumours (PNETs) or Ewing sarcoma. It involves the use of powerful anti-cancer drugs such as vincristine, doxorubicin, cyclophosphamide, and etoposide. Chemotherapy may be given before surgery to shrink the tumour (neoadjuvant therapy) or after surgery to destroy any remaining cancer cells (adjuvant therapy). It can also be the main treatment when surgery isn't possible or if the cancer has spread to other parts of the body.

Stem Cell Implant

In certain high-risk or relapsed cases of neuroectodermal tumour treatment, stem cell transplant is considered. This approach involves giving high-dose chemotherapy to kill cancer cells followed by the infusion of healthy stem cells to restore the bone marrow. It is mostly used in pediatric patients with recurrent tumours like medulloblastoma. The procedure helps the patient recover faster from intensive chemotherapy and offers a chance for longer remission in aggressive cases. However, it carries risks and is usually done in specialised cancer centres.

Immunotherapy

Immunotherapy works by boosting the body’s immune system to fight cancer cells. It includes treatments like checkpoint inhibitors, which remove the “brakes” from immune cells so they can attack tumours more effectively. While not yet widely used for most neuroectodermal tumours, immunotherapy is being explored in clinical trials for patients who do not respond to conventional treatments. Research is ongoing, and some early results show potential, especially in tumours with specific immune-related markers.

Hospital For Neuroectodermal Tumours Treatment

There are different hospitals for tumour treatment. They give malignancy-oriented treatment to the patients. Palliative care is provided alongside curative treatment or as the main approach when active cancer treatment is no longer effective. It includes medical, psychological, and supportive services tailored to the patient’s needs and can greatly improve comfort and well-being. For patients with rare, recurrent, or treatment-resistant neuroectodermal tumours, clinical trials provide access to advanced therapies that are not yet available to the general public.

Location	Cities
Tata Memorial Hospital	Mumbai, Maharashtra
All India Institute of Medical Sciences (AIIMS)	New Delhi
Apollo Hospitals	Chennai, Tamil Nadu
Christian Medical College (CMC)	Vellore, Tamil Nadu
Fortis Memorial Research Institute	Gurugram, Haryana
Medanta – The Medicity	Gurugram, Haryana
Rajiv Gandhi Cancer Institute	Delhi
Kokilaben Dhirubhai Ambani Hospital	Mumbai, Maharashtra
PGIMER (Postgraduate Institute)	Chandigarh
Max Super Speciality Hospital	Delhi
HCG Cancer Centre	Bangalore, Karnataka
Narayana Health City	Bangalore, Karnataka
Amrita Institute of Medical Sciences	Kochi, Kerala
Sir Ganga Ram Hospital	New Delhi
KIMS (Krishna Institute of Medical Sciences)	Hyderabad, Telangana

Cost of Neuroectodermal Tumours Treatment

The total cost of neuroectodermal tumours treatment in India can range from ₹4 lakh to ₹30 lakh or more, depending on tumour complexity, treatment plan, and hospital infrastructure. Public hospitals like AIIMS offer subsidised or free care for eligible patients, while private hospitals may provide premium but costlier services. Advanced treatments like stem cell transplants or targeted therapy significantly increase the overall cost. It’s essential to get a detailed treatment estimate from the chosen hospital and inquire about insurance coverage or financial aid programs.

Book Appointment

Get a free quote

Estimated Cost (INR)	Cost in INR
Surgical Tumour Removal	₹2,50,000 – ₹6,00,000
Chemotherapy (full cycle)	₹1,50,000 – ₹5,00,000
Radiation Therapy (IMRT/IGRT)	₹1,20,000 – ₹3,50,000
Stem Cell / Bone Marrow Transplant	₹10,00,000 – ₹25,00,000
Targeted Therapy (if applicable)	₹80,000 – ₹2,50,000/month
Immunotherapy (experimental/optional)	₹1,50,000 – ₹4,00,000/month
Hospital Stay (per day)	₹5,000 – ₹15,000
Diagnostic Tests & Imaging	₹40,000 – ₹1,00,000
Follow-up & Supportive Care	₹20,000 – ₹80,000/year

We Care Health Services For Neuroectodermal Tumours Treatment

We Care Health Services stands out as a trusted healthcare facilitator offering access to top oncologists, neurosurgeons, and cancer hospitals across India. Their personalised, patient-first approach ensures that individuals battling neuroectodermal tumours receive the best care, right from diagnosis to recovery. They simplify the complex treatment process by coordinating appointments, hospital admissions, second opinions, and follow-ups, making high-quality cancer care accessible, affordable, and less stressful for patients and families.

Access to Top Cancer Hospitals
Connects patients with India’s leading cancer centres like Tata Memorial, AIIMS, Apollo, and more.
Expert Oncologist Network
Offers referrals to highly experienced specialists in neuro-oncology, pediatric oncology, and advanced surgical oncology.
Affordable Treatment Packages
Helps arrange cost-effective packages for surgery, chemotherapy, radiation, and advanced therapies like stem cell transplant.
Support at Every Step
Full guidance with treatment planning, travel, visa, accommodation, and recovery support—ideal for both Indian and international patients.
Fast Appointments & Second Opinions
Quick coordination for consultations, reducing waiting times and ensuring timely diagnosis and treatment.
Multilingual & Compassionate Team
Provides language support and emotional counselling to ensure patients and families feel understood and cared for.
Tailored Treatment Guidance
Recommends hospitals and specialists based on tumour type, stage, age group (especially pediatric cases), and budget.
Post-Treatment Follow-Up
Assists with long-term care planning, rehabilitation, and lifestyle support after cancer treatment.

Frequently Asked Questions:

1What is the best treatment for neuroendocrine tumours?

The best treatment for neuroendocrine tumours (NETs) depends on the type, location, and stage of the tumour. Surgery is the preferred option if the tumour is localised and operable. For advanced cases, targeted therapy, somatostatin analogues (like octreotide), chemotherapy, and peptide receptor radionuclide therapy (PRRT) are commonly used. In some cases, a combination of treatments may be recommended for better control. Regular monitoring and personalised treatment plans are key. A multidisciplinary approach involving oncologists, endocrinologists, and surgeons ensures the best outcomes for patients with NETs.

2Is neuroblastoma a neuroectodermal tumor?

Yes, neuroblastoma is a type of neuroectodermal tumour. It arises from immature nerve cells called neuroblasts, which originate in the neural crest—a part of the embryonic neuroectoderm. Neuroblastoma most commonly affects infants and young children and usually develops in the adrenal glands, though it can also occur in the chest, abdomen, or spine. As a neuroectodermal tumor, it shares developmental origins with other tumours of the nervous system, but has its own distinct clinical and biological features.

3What is an embryonic-type neuroectodermal tumour?

Embryonic-type neuroectodermal tumours are aggressive cancers that develop from primitive nerve cells originating in the embryonic neuroectoderm. These tumours typically occur in children and young adults. They include types like medulloblastoma and primitive neuroectodermal tumours (PNETs). Characterised by rapid growth, they often arise in the brain or spine and require intensive treatment, including surgery, chemotherapy, and radiation.

4What is a neuroectodermal tumour in the kidney?

A neuroectodermal tumour in the kidney, often referred to as renal PNET (primitive neuroectodermal tumour), is a rare and aggressive cancer. It originates from neural crest cells and typically affects young adults. Symptoms may include abdominal pain, mass, or blood in the urine. Treatment involves surgery, chemotherapy, and sometimes radiation.